Dietary Counseling Aimed at Reducing Sugar Intake Yields the Greatest Improvement in Management of Weight and Metabolic Dysfunction in Children with Obesity.
dietary counseling
metabolic dysfunction
obesity
pediatric
sugar
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
03 Apr 2022
03 Apr 2022
Historique:
received:
11
03
2022
revised:
27
03
2022
accepted:
01
04
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
14
4
2022
Statut:
epublish
Résumé
Pediatric obesity is a significant public health problem, the negative outcomes of which will challenge individual well-being and societal resources for decades to come. The objective of this study was to determine the effects of dietary counseling on weight management and metabolic abnormalities in children with obesity. One hundred and sixty-five patients aged 2−18 years old were studied over a two and a half year period. Data collected included demographic information, anthropometric assessment, laboratory measurements, and self-reported eating behaviors. Dietary counseling was provided at each visit. The data was analyzed from the first and last visits and the subjects were retrospectively divided into responders and non-responders based on a decrease in their BMI. After receiving dietary guidance, BMI decreased in 44% of the children, and these participants were classified as responders (BMI-R; n = 72). However, BMI did not improve in 56% of the participants, and these were classified as non-responders (BMI-NR; n = 93). At the initial visit, anthropometric measurements and dietary habits were similar between the groups. At the time of the last visit, mean change in BMI was −1.47 (SD 1.31) for BMI-R and +2.40 (SD 9.79) for BMI-NR. Analysis of food intake revealed that BMI-R significantly improved their dietary habits (p = 0.002) by reducing the intake of sugar-sweetened beverages (p = 0.019), processed foods (p = 0.002), sweets (p < 0.001), and unhealthy snacks (p = 0.009), as compared with BMI-NR. There was no change in the intake of second helpings, portion sizes, skipping meals, frequency of meals eaten at school, condiment use, intake of fruits and vegetables and consumption of whole grains between the groups. BMI-R also achieved an improvement in fasted glucose (p = 0.021), triglycerides (p < 0.001), and total cholesterol (p = 0.023), as compared to BMI-NR. In conclusion, children with obesity who were able to decrease their BMI implemented a significant reduction in consumption of foods with high sugar content. Focusing on reducing sugar intake may yield the biggest impact in terms of weight management and the improvement of metabolic abnormalities.
Identifiants
pubmed: 35406113
pii: nu14071500
doi: 10.3390/nu14071500
pmc: PMC9003198
pii:
doi:
Substances chimiques
Sugars
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM103527
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM127211
Pays : United States
Organisme : NIH HHS
ID : P30 GM127211
Pays : United States
Références
Nutr Metab (Lond). 2005 Feb 21;2(1):5
pubmed: 15723702
J Clin Endocrinol Metab. 2017 Mar 1;102(3):763-775
pubmed: 28359101
Early Hum Dev. 2010 Nov;86(11):715-22
pubmed: 20846795
Obes Rev. 2019 Jun;20(6):871-882
pubmed: 30734459
Cell Metab. 2019 Oct 1;30(4):735-753.e4
pubmed: 31577934
Crit Rev Clin Lab Sci. 2020 Aug;57(5):308-322
pubmed: 31935149
Circulation. 2009 Sep 15;120(11):1011-20
pubmed: 19704096
Nat Rev Endocrinol. 2022 Apr;18(4):205-218
pubmed: 35064240
Dig Dis Sci. 2016 May;61(5):1282-93
pubmed: 26856717
Pediatrics. 2005 Jun;115(6):1723-33
pubmed: 15930237
Pediatr Obes. 2022 Mar;17(3):e12862
pubmed: 34662928
Pediatrics. 2007 Dec;120 Suppl 4:S254-88
pubmed: 18055654
J Hepatol. 2018 May;68(5):1063-1075
pubmed: 29408694
Can J Diabetes. 2013 Apr;37 Suppl 1:S45-55
pubmed: 24070963
Diabetes. 2016 Aug;65(8):2187-200
pubmed: 27207510
Science. 2008 Jun 13;320(5882):1492-6
pubmed: 18556558
Am J Clin Nutr. 2010 Jun;91(6):1560-7
pubmed: 20375189
Am J Clin Nutr. 2009 Jun;89(6):1760-5
pubmed: 19403641
Circulation. 2003 Mar 25;107(11):1562-6
pubmed: 12654618
Pediatrics. 2004 Jul;114(1):e29-36
pubmed: 15231970
J Clin Endocrinol Metab. 2017 Mar 01;102(3):709-757
pubmed: 28359099
Hepatology. 2022 Jan 9;:
pubmed: 35000211
STAR Protoc. 2021 Aug 09;2(3):100731
pubmed: 34409309
J Clin Invest. 2021 Dec 15;131(24):
pubmed: 34907907
N Engl J Med. 1997 Sep 25;337(13):869-73
pubmed: 9302300
Adv Nutr. 2017 Jan 17;8(1):54-62
pubmed: 28096127
Atherosclerosis. 2016 Oct;253:171-177
pubmed: 27451002
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1278-1283
pubmed: 34529635
Gastroenterology. 2017 Sep;153(3):743-752
pubmed: 28579536
Curr Diab Rep. 2020 Oct 15;20(11):64
pubmed: 33057854
Public Health Nutr. 2004 Feb;7(1A):245-50
pubmed: 14972063
J Am Diet Assoc. 2005 May;105(5 Suppl 1):S44-51
pubmed: 15867895
Front Nutr. 2022 Jan 13;8:748847
pubmed: 35118102
J Clin Res Pediatr Endocrinol. 2017 Jun 1;9(2):111-117
pubmed: 28008863
J Clin Invest. 2017 Nov 1;127(11):4059-4074
pubmed: 28972537
Eur J Gastroenterol Hepatol. 2019 Jan;31(1):143
pubmed: 30507644
Obesity (Silver Spring). 2013 Apr;21(4):815-23
pubmed: 23712985
Pediatr Int. 2011 Jun;53(3):303-8
pubmed: 20831653
J Clin Endocrinol Metab. 2019 Jul 1;104(7):3003-3011
pubmed: 30869790
Aliment Pharmacol Ther. 2012 May;35(10):1135-44
pubmed: 22469071
Pediatr Obes. 2013 Jun;8(3):159-69
pubmed: 23042783
Obes Facts. 2016;9(2):65-90
pubmed: 27055256
Am J Clin Nutr. 2004 Apr;79(4):537-43
pubmed: 15051594
Obesity (Silver Spring). 2016 Feb;24(2):453-60
pubmed: 26499447
J Intern Med. 2017 Aug;282(2):187-201
pubmed: 28548281
Int J Obes (Lond). 2021 Nov;45(11):2377-2387
pubmed: 34302121
Clin Transl Sci. 2021 Jan;14(1):11-19
pubmed: 32583961
PLoS One. 2012;7(6):e38952
pubmed: 22745692
Mayo Clin Proc. 2017 Feb;92(2):251-265
pubmed: 28065514
Pediatrics. 2007 Dec;120 Suppl 4:S164-92
pubmed: 18055651
J Clin Invest. 2009 May;119(5):1322-34
pubmed: 19381015
Am J Clin Nutr. 2002 Nov;76(5):911-22
pubmed: 12399260